Market Analysts see Mustang Bio Inc [MBIO] gaining to $11. Time to buy?

TANH

Mustang Bio Inc [NASDAQ: MBIO] closed the trading session at $411960.0 on 2025-07-01. The day’s price range saw the stock hit a low of $0.8926, while the highest price level was $2.13.

The stocks have a year to date performance of -91.19 percent and weekly performance of 89.81 percent. The stock has been moved at -76.70 percent over the last six months. The stock has performed 56.49 percent around the most recent 30 days and changed 64.00 percent over the most recent 3-months.

If compared to the average trading volume of 411.96K shares, MBIO reached to a volume of 28005494 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here’s what leading stock market gurus have to say about Mustang Bio Inc [MBIO]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MBIO shares is $500.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MBIO stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

BTIG Research have made an estimate for Mustang Bio Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on May 18, 2021. While these analysts kept the previous recommendation, B. Riley FBR raised their target price to Buy. The new note on the price target was released on October 02, 2020, representing the official price target for Mustang Bio Inc stock. Previously, the target price had yet another raise to $7, while Cantor Fitzgerald analysts kept a Overweight rating on MBIO stock.

The Price to Book ratio for the last quarter was 1.92, with the Price to Cash per share for the same quarter was set at 3.25.

MBIO stock trade performance evaluation

Mustang Bio Inc [MBIO] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 89.81. With this latest performance, MBIO shares gained by 56.49% in over the last four-week period, additionally sinking by -76.70% over the last 6 months – not to mention a drop of -76.84% in the past year of trading.

Mustang Bio Inc [MBIO]: An insightful look at the core fundamentals

Return on Equity for this stock declined to -72.63%, with Return on Assets sitting at -72.63%.

Mustang Bio Inc [MBIO]: Institutional Ownership

There are presently around $6.88%, or 7.73%% of MBIO stock, in the hands of institutional investors. The top three institutional holders of MBIO stocks are: UBS GROUP AG with ownership of 0.19 million shares, which is approximately 0.0445%. KOSS-OLINGER CONSULTING, LLC, holding 98366.0 shares of the stock with an approximate value of $$47000.0 in MBIO stocks shares; and KOSS-OLINGER CONSULTING, LLC, currently with $$41253.0 in MBIO stock with ownership which is approximately 0.0201%.

The DBT News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.